UTICA, N.Y., Aug. 16 /PRNewswire-FirstCall/ --
CONMED Corporation (Nasdaq: CNMD) announced today that in celebration of its
15 years of trading on the Nasdaq, ConMed will open The Nasdaq Stock Market on
Tuesday, August 20, 2002 in a ceremony led by Eugene Corasanti and Joseph
Corasanti, the Company's CEO and COO, respectively. "We are proud to have
been chosen to open the Nasdaq in honor of this 15-year milestone," commented
Joseph J. Corasanti, President and COO of CONMED Corporation.
Mr. Joseph Corasanti is also scheduled to be interviewed by Liz Claman on
the CNBC show "Wake Up Call" at approximately 6:40 am Eastern time on
Tuesday, August 20, 2002.
Mr. Corasanti continued, "Over the past 15 years, CONMED has evolved from
a company that sold a narrow line of hospital supplies and commodity products
into a leading medical technology company. We now have at least a number two
market position in arthroscopy, powered surgical instruments, electrosurgery
and patient care -- and continued double-digit growth in endoscopy, following
our recently completed acquisition of Imagyn's product line. Further, since
joining the Nasdaq in 1987, CONMED's profitability has expanded significantly,
as net income has grown 25 fold."
ConMed began trading on the Nasdaq on August 18, 1987.
CONMED is a medical technology company specializing in instruments,
implants, and video equipment for arthroscopic sports medicine, and powered
surgical instruments, such as drills and saws, for orthopedic, ENT,
neuro-surgery, and other surgical specialties. The Company is also a leading
developer, manufacturer and supplier of RF electrosurgery systems used
routinely to cut and cauterize tissue in nearly all types of all surgical
procedures worldwide, and endoscopy products such as trocars, clip appliers,
scissors, and surgical staplers.
Company also manufactures and sells a full line of ECG electrodes for
heart monitoring and other patient care products. Headquartered in Utica,
New York, the Company's 2,500 employees distribute its products worldwide from
eight manufacturing locations.
This press release contains forward-looking statements based on certain
assumptions and contingencies that involve risks and uncertainties. The
forward-looking statements are made pursuant to the safe harbor provisions of
the Private Securities Litigation Reform Act of 1995 and relate to the
Company's performance on a going-forward basis. The forward-looking
statements in this press release involve risks and uncertainties which could
cause actual results, performance or trends, to differ materially from those
expressed in the forward-looking statements herein or in previous disclosures.
The Company believes that all forward-looking statements made by it have a
reasonable basis, but there can be no assurance that management's
expectations, beliefs or projections as expressed in the forward-looking
statements will actually occur or prove to be correct. In addition to general
industry and economic conditions, factors that could cause actual results to
differ materially from those discussed in the forward-looking statements in
this press release include, but are not limited to: (i) the failure of any one
or more of the assumptions stated above, to prove to be correct; (ii) the
risks relating to forward-looking statements discussed in the Company's Annual
Report on Form 10-K for the fiscal year ended December 31, 2001 and the
Prospectus dated May 22, 2002; (iii) cyclical purchasing patterns from
customers, end-users and dealers; (iv) timely release of new products, and
acceptance of such new products by the market; (v) the introduction of new
products by competitors and other competitive responses; (vi) the possibility
that any new acquisition or other transaction may require the Company to
reconsider its financial assumptions and goals/targets; and/or (vii) the
Company's ability to devise and execute strategies to respond to market
conditions.
SOURCE CONMED Corporation
 back to top
Related links:
http://www.conmed.com
Company News On-Call:
http://www.prnewswire.com/comp/201850.html
CONTACT:
Robert Shallish, Chief Financial Officer,
CONMED Corporation, +1-315-624-3206; Investors - Lauren Levine,
or Lanie Fladell, +1-212-850-5600, Media - Dan Budwick,
+1-212-850-5600, all of Morgen-Walke Associates, for CONMED
Corporation
|
